206 related articles for article (PubMed ID: 26556999)
21. Comparative study of serotonin and bombesin in adenocarcinomas and neuroendocrine tumors of the colon.
Seretis E; Gavrill A; Agnantis N; Golematis V; Voloudakis-Baltatzis IE
Ultrastruct Pathol; 2001; 25(6):445-54. PubMed ID: 11783909
[TBL] [Abstract][Full Text] [Related]
22. Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential.
Gao W; Chen L; Ma Z; Du Z; Zhao Z; Hu Z; Li Q
Gastroenterology; 2013 Sep; 145(3):636-46.e5. PubMed ID: 23747337
[TBL] [Abstract][Full Text] [Related]
23. Expression of ITGB1 predicts prognosis in colorectal cancer: a large prospective study based on tissue microarray.
Liu QZ; Gao XH; Chang WJ; Gong HF; Fu CG; Zhang W; Cao GW
Int J Clin Exp Pathol; 2015; 8(10):12802-10. PubMed ID: 26722470
[TBL] [Abstract][Full Text] [Related]
24. [Research progression in colorectal cancer stem cells].
Wu TY; Cui L
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):297-300. PubMed ID: 23536355
[TBL] [Abstract][Full Text] [Related]
25. ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms.
Ramage JK; De Herder WW; Delle Fave G; Ferolla P; Ferone D; Ito T; Ruszniewski P; Sundin A; Weber W; Zheng-Pei Z; Taal B; Pascher A;
Neuroendocrinology; 2016; 103(2):139-43. PubMed ID: 26730835
[No Abstract] [Full Text] [Related]
26. Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal Cancer.
Su S; Hong F; Liang Y; Zhou J; Liang Y; Chen K; Wang X; Wang Z; Wang Z; Chang C; Han W; Gong W; Qin H; Jiang B; Xiong H; Peng L
PLoS One; 2015; 10(11):e0143513. PubMed ID: 26599100
[TBL] [Abstract][Full Text] [Related]
27. INSL5 may be a unique marker of colorectal endocrine cells and neuroendocrine tumors.
Mashima H; Ohno H; Yamada Y; Sakai T; Ohnishi H
Biochem Biophys Res Commun; 2013 Mar; 432(4):586-92. PubMed ID: 23438439
[TBL] [Abstract][Full Text] [Related]
28. Meta-iodobenzylguanidine induces growth inhibition and apoptosis of neuroendocrine gastrointestinal tumor cells.
Höpfner M; Sutter AP; Beck NI; Barthel B; Maaser K; Jockers-Scherübl MC; Zeitz M; Scherübl H
Int J Cancer; 2002 Sep; 101(3):210-6. PubMed ID: 12209970
[TBL] [Abstract][Full Text] [Related]
29. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
Alqurashi N; Gopalan V; Smith RA; Lam AK
Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
[TBL] [Abstract][Full Text] [Related]
30. Neuroendocrine-like cells -derived CXCL10 and CXCL11 induce the infiltration of tumor-associated macrophage leading to the poor prognosis of colorectal cancer.
Zeng YJ; Lai W; Wu H; Liu L; Xu HY; Wang J; Chu ZH
Oncotarget; 2016 May; 7(19):27394-407. PubMed ID: 27034164
[TBL] [Abstract][Full Text] [Related]
31. Significance of mTOR signaling and its inhibitor against cancer stem-like cells in colorectal cancer.
Cai Z; Ke J; He X; Yuan R; Chen Y; Wu X; Wang L; Wang J; Lan P; Wu X
Ann Surg Oncol; 2014 Jan; 21(1):179-88. PubMed ID: 23907312
[TBL] [Abstract][Full Text] [Related]
32. High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients.
Chen X; Sun K; Jiao S; Cai N; Zhao X; Zou H; Xie Y; Wang Z; Zhong M; Wei L
Sci Rep; 2014 Dec; 4():7481. PubMed ID: 25500546
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: diagnostic and prognostic features.
Faggiano A; Sabourin JC; Ducreux M; Lumbroso J; Duvillard P; Leboulleux S; Dromain C; Colao A; Schlumberger M; Baudin E
Cancer; 2007 Jul; 110(2):265-74. PubMed ID: 17569104
[TBL] [Abstract][Full Text] [Related]
34. [Relationship between E-CD and Snail expressions and tumor invasion, metastasis and prognosis in colorectal cancer].
Zheng BA; Deng GL; Dong QJ; Zhao ZS; Deng YC
Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):111-6. PubMed ID: 20403241
[TBL] [Abstract][Full Text] [Related]
35. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms.
Caplin M; Sundin A; Nillson O; Baum RP; Klose KJ; Kelestimur F; Plöckinger U; Papotti M; Salazar R; Pascher A;
Neuroendocrinology; 2012; 95(2):88-97. PubMed ID: 22261972
[No Abstract] [Full Text] [Related]
36. Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung.
Righi L; Volante M; Rapa I; Tavaglione V; Inzani F; Pelosi G; Papotti M
Endocr Relat Cancer; 2010 Dec; 17(4):977-87. PubMed ID: 20817788
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
Zhai H; Fesler A; Ba Y; Wu S; Ju J
Oncotarget; 2015 Aug; 6(23):19735-46. PubMed ID: 25980495
[TBL] [Abstract][Full Text] [Related]
38. Gastroenteropancreatic neuroendocrine tumor cancer stem cells: do they exist?
Grande E; Capdevila J; Barriuso J; Antón-Aparicio L; Castellano D
Cancer Metastasis Rev; 2012 Jun; 31(1-2):47-53. PubMed ID: 22105614
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary neuroendocrine/carcinoid tumors: a review article.
Bertino EM; Confer PD; Colonna JE; Ross P; Otterson GA
Cancer; 2009 Oct; 115(19):4434-41. PubMed ID: 19562772
[TBL] [Abstract][Full Text] [Related]
40. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
Cox ME; Deeble PD; Lakhani S; Parsons SJ
Cancer Res; 1999 Aug; 59(15):3821-30. PubMed ID: 10447001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
